Circumvention of Mcl-1-dependent drug resistance by simultaneous Chk1 and MEK1/2 inhibition in human multiple myeloma cells von Pei, Xin-Yan, Dai, Yun, Felthousen, Jessica, Chen, Shuang, Takabatake, Yukie, Zhou, Liang, Youssefian, Leena E, Sanderson, Michael W, Bodie, Wesley W, Kramer, Lora B, Orlowski, Robert Z, Grant, Steven

Volltext

Cytokinetically quiescent (G0/G1) human multiple myeloma cells are susceptible to simultaneous inhibition of Chk1 and MEK1/2 von Pei, Xin-Yan, Dai, Yun, Youssefian, Leena E., Chen, Shuang, Bodie, Wesley W., Takabatake, Yukie, Felthousen, Jessica, Almenara, Jorge A., Kramer, Lora B., Dent, Paul, Grant, Steven

Volltext

Erratum to: Phase I trial of bortezomib and dacarbazine in melanoma and soft tissue sarcoma von Poklepovic, Andrew, Youssefian, Leena E., Winning, Mary, Birdsell, Christine A., Crosby, Nancy A., Ramakrishnan, Viswanathan, Ernstoff, Marc S., Roberts, John D.

Volltext

Bcl-2 Antagonism Potentiates MEK1/2/Chk1 Inhibitor Lethality in Multiple Myeloma Cells Overexpressing Bcl-2 through a Stat3-Dependent Mechanism von Pei, Xin-Yan, Sanderson, Michael W, Youssefian, Leena E, Felthousen, Jessica, Kramer, Lora B, Dai, Yun, Grant, Steven

Volltext

Abstract 3390: Simultaneous Chk1 and MEK1/2 inhibition circumvents Mcl-1-mediated anti-apoptotic functions and bortezomib resistance in human multiple myeloma cells von Pei, Xin-Yan, Dai, Yun, Felthousen, Jessica, Chen, Shuang, Takabatake, Yukie, Youssefian, Leena E., Bodie, Wesley W., Kramer, Lora B., Orlowski, Robert Z., Grant, Steven

Volltext

Phase I trial of bortezomib and dacarbazine in melanoma and soft tissue sarcoma von Poklepovic, Andrew, Youseffian, Leena, Winning, Mary, Birdsell, Christine A., Crosby, Nancy A., Ramakrishnan, Viswanathan, Ernstoff, Marc S., Roberts, John D.

Volltext

Abstract 4667: Simultaneous Chk1 and MEK1/2 inhibition circumvents Mcl-1 anti-apoptotic function and bortezomib resistance in human multiple myeloma cells von Pei, Xin-Yan, Dai, Yun, Felthousen, Jessica, Chen, Shuang, Wang, Li, Takabatake, Yukie, Youssefian, Leena E., Bodie, Wesley W., Kramer, Lora, Grant, Steven

Volltext

Abstract 5367: Simultaneous inhibition of Chk1 and MEK1/2 targets non-proliferating multiple myeloma cells von Pei, Xin-Yan, Dai, Yun, Youssefian, Leena E., Chen, Shuang, Bodie, Wesley, Takabatake, Yukie, Almenara, George, Kramer, Lora, Dent, Paul, Grant, Steven

Volltext

Cytokinetically quiescent (G0/G1) human multiple myeloma cells are susceptible to simultaneous inhibition of Chkl and MEK1/2 von PEI, Xin-Yan, YUN DAI, GRANT, Steven, YOUSSEFIAN, Leena E, SHUANG CHEN, BODIE, Wesley W, TAKABATAKE, Yukie, FELTHOUSEN, Jessica, ALMENARA, Jorge A, KRAMER, Lora B, DENT, Paul

Volltext

Circumvention of Mcl-1-Dependent Drug Resistance by Simultaneous Chk1 and MEK1/2 Inhibition in Human Multiple Myeloma Cells: e89064 von Pei, Xin-Yan, Dai, Yun, Felthousen, Jessica, Chen, Shuang, Takabatake, Yukie, Zhou, Liang, Youssefian, Leena E, Sanderson, Michael W, Bodie, Wesley W, Kramer, Lora B

Volltext

Circumvention of Mcl-1-Dependent Drug Resistance by Simultaneous Chk1 and MEK1/2 Inhibition in Human Multiple Myeloma Cells von Pei, Xin-Yan, Dai, Yun, Felthousen, Jessica, Shen, Shuang, Takabatake, Yukie, Zhou, Liang, Youssefian, Leena E, Sanderson, Michael W, Bodie, Wesley W, Kramer, Lora B, Orlowski, Robert Z, Grant, Steven

Volltext bestellen